UroGen Pharma Appoints David Lin as New Chief Commercial Officer
Go back to UroGen Pharma Appoints David Lin as New Chief Commercial Officer| (NASDAQ: URGN) | Delayed: 40.20 +0.20 (0.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.00 | 52 Week High | $ | |||
| Open | $39.82 | 52 Week Low | $ | |||
| Day High | $41.88 | P/E | N/A | |||
| Day Low | $39.50 | EPS | $ | |||
| Volume | 856,171 | |||||
